We are live on
!
Find out more
KCM
KRS Capital Management Portfolio holdings
AUM
$215M
1-Year Est. Return
69.3%
This Fund
S&P 500
This Quarter
Est. Return
+5.58%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$137M
AUM Growth
+$3.56M
(+2.7%)
Cap. Flow
-$2.23M
Cap. Flow
% of AUM
-1.62%
Top 10 Holdings %
Top 10 Hldgs %
52.9%
Holding
119
New
4
Increased
24
Reduced
74
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$456K |
| 2 |
AeroVironment
AVAV
|
+$293K |
| 3 |
Palantir
PLTR
|
+$236K |
| 4 |
Pfizer
PFE
|
+$223K |
| 5 |
Amazon
AMZN
|
+$171K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$386K |
| 2 |
Chevron
CVX
|
+$317K |
| 3 |
Boeing
BA
|
+$303K |
| 4 |
Edwards Lifesciences
EW
|
+$253K |
| 5 |
SLB Ltd
SLB
|
+$147K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 59.11% |
| 2 | Healthcare | 13.38% |
| 3 | Financials | 5.97% |
| 4 | Consumer Discretionary | 5.16% |
| 5 | Industrials | 5.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
TSMC
TSM
$2.17T
| $262K | 0.19% |
1,507
+120
| +9% | +$20.4K |
|
102
Workday
WDAY
$42B
| $259K | 0.19% |
1,060
-10
| -0.9% | -$2.36K |
|
103
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $251K | 0.18% |
2,543
-15
| -0.6% | -$1.47K |
|
104
Autoliv
ALV
$8.83B
| $251K | 0.18% |
2,683
-105
| -4% | -$10.5K |
|
105
Constellation Brands
STZ
$22.6B
| $232K | 0.17% |
900
-111
| -11% | -$27.5K |
|
106
Teradyne
TER
$60.2B
| $230K | 0.17% |
1,715
-261
| -13% | -$35.2K |
|
|
107
Pfizer
PFE
$149B
| $221K | 0.16% |
+7,648
| New | +$223K |
|
108
Carlyle Group
CG
$17.6B
| $220K | 0.16% |
5,120
| – | – |
|
109
Phillips 66
PSX
$82.4B
| $217K | 0.16% |
1,651
-586
| -26% | -$79.1K |
|
110
Electronic Arts
EA
| $216K | 0.16% |
1,505
| – | – |
|
111
FedEx
FDX
$74.7B
| $213K | 0.16% |
780
-9
| -1% | -$2.61K |
|
112
Owens Corning
OC
$12.1B
| $212K | 0.15% |
1,200
| – | – |
|
|
NVO
113
Novo Nordisk
NVO
$203B
| $208K | 0.15% |
1,745
| – | – |
|
114
Coca-Cola
KO
$374B
| $206K | 0.15% |
2,862
-328
| -10% | -$22.5K |
|
115
Snowflake
SNOW
$110B
| $203K | 0.15% |
1,770
-505
| -22% | -$62.1K |
|
116
Cirrus Logic
CRUS
$6.23B
| $202K | 0.15% |
1,625
+50
| +3% | +$6.62K |
|
|
117
Boeing
BA
$184B
| – | – |
-1,667
| Closed | -$303K |
|
|
118
DexCom
DXCM
$31.3B
| – | – |
-3,402
| Closed | -$386K |
|
|
119
Edwards Lifesciences
EW
$51.5B
| – | – |
-2,735
| Closed | -$253K |
|
Similar funds
VFG
IAM
VEA
RC
NCM
TSS
CMBA
IH
KRS Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, KRS Capital Management held 119 positions worth $137M, up 2.7% from $134M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
KRS Capital Management's Q3 2024 filing shows 4 new, 24 increased, 74 reduced and 3 closed positions. Its largest new stake was Micron Technology: 4,360 shares worth $452K. The largest sale was DexCom, an estimated $386K.
By sector, the portfolio is most concentrated in Technology at 59% of assets, down from 59% a quarter earlier, followed by Healthcare and Financials.
- KRS Capital Management's largest Q3 2024 buy was Micron Technology: 4,360 shares worth $452K.
- KRS Capital Management added most to Amazon in Q3 2024, an estimated $171K increase.
- KRS Capital Management's biggest Q3 2024 reduction was Chevron, cutting an estimated $317K.
- KRS Capital Management fully exited DexCom in Q3 2024, selling an estimated $386K.
- KRS Capital Management's ten largest holdings make up 53% of its $137M portfolio in Q3 2024.
- KRS Capital Management opened 4 new positions and closed 3 in Q3 2024.
- KRS Capital Management's portfolio value rose 2.7% quarter-over-quarter to $137M.
Based on KRS Capital Management's 13F filing for Q3 2024, filed 15 Oct 2024.